FDA Adverse Event Injury Summary report: N

WATCHMAN FLX? PRO

MDR report key: 22197198 · Received June 12, 2025

Report

Report Number
2124215-2025-38848
Event Type
Injury
Date Received
June 12, 2025
Date of Event
May 2, 2025
Report Date
June 12, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
UDI-DI
00191506004606
PMA / PMN Number
P130013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

IT WAS REPORTED A TRANSIENT ISCHEMIC ATTACK (TIA) OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS PERFORMED AND A 27MM WATCHMAN FLX PRO CLOSURE DEVICE WAS IMPLANTED. 55 DAY ECHOCARDIOGRAM PERFORMED SHOWED THE CLOSURE DEVICE STABLE AT LAA OSTIUM WITH NO LEAK PRESENT. 64 DAYS POST INDEX PROCEDURE, THE PATIENT PRESENTED TO THE HOSPITAL WITH BILATERAL TREMULOUSNESS IN UPPER EXTREMITIES, CHEST PAIN, WITH A SUSPECTED STROKE. THE SYMPTOMS LASTED SEVERAL HOURS. BY THE TIME THE DIAGNOSTICS (LABS, COMPUTED TOMOGRAPHY (CT) SCAN, AND MAGNETIC RESONANCE IMAGING (MRI) SCAN) WERE FINISHED, SYMPTOMS DISSIPATED. THE PHYSICIANS SAW EVIDENCE OF A TRANSIENT ISCHEMIC ATTACK (TIA) AND NOT A STROKE. MRI RESULTS SHOWED NO ACUTE INFARCTION, HEMORRHAGE, OR INTRACRANIAL MASS LESION. AT THE TIME OF THE EVENT, THE PATIENT WAS STILL ON RIVAROXABAN. THE PATIENT HAD A ORAL MEDICATION CHANGE/ADJUSTMENT OTHER THAN ANTITHROMBOTIC, PERFORMED AS THE CORRECTIVE ACTION TO THE EVENT. THE PATIENT SPENT TWO (2) NIGHTS ADMITTED TO THE HOSPITAL AND THEN WAS DISCHARGED HOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2033354 WATCHMAN FLX? PRO SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION M635WU60270 0035473154 00191506004606

Patients

Seq Age Sex Outcome Treatment
1 79 YR Female Hospitalization| R